T85.730 Infection and inflammatory reaction due to ventricular intracranial (communicating) shunt

Name of the Condition

• Infection and inflammatory reaction due to ventricular intracranial (communicating) shunt

Summary

This condition involves infections or inflammatory responses associated with a ventricular intracranial (communicating) shunt, a device used to manage cerebrospinal fluid flow. It includes localized or systemic reactions to the shunt, such as bacterial or fungal infections, or non-infectious inflammatory processes. The code T85.730 is used when these reactions are directly linked to the shunt but do not fall into narrower categories.

Causes

Infections or inflammatory reactions may result from bacterial contamination during shunt insertion, biofilm formation on the device surface, or immune responses to the shunt material. Surgical errors, poor wound healing, or pre-existing infections can also contribute to these complications. Inflammatory reactions may arise from the body's response to foreign material or device degradation over time.

Risk Factors

• Use of a ventricular intracranial (communicating) shunt
• Previous history of device-related infections or inflammation
• Underlying conditions affecting immune function (e.g., immunosuppression)
• Prolonged device use or inadequate maintenance
• Poor surgical technique or postoperative care

Symptoms

• Headache or increased intracranial pressure
• Fever or chills
• Nausea, vomiting, or altered mental status
• Pain, swelling, or redness at the shunt site
• Purulent drainage or discharge from the site
• Seizures or neurological deficits

Diagnosis

Diagnosis is based on clinical evaluation, including assessment of symptoms and physical examination of the shunt site. Laboratory tests, such as cerebrospinal fluid analysis (cell count, culture) and imaging studies (e.g., CT or MRI), may be used to confirm infection or inflammation. Clinical correlation with device history is essential.

Treatment Options

Treatment typically involves antimicrobial therapy tailored to the identified pathogen, often requiring shunt removal or revision. Supportive care, such as managing intracranial pressure, may be necessary. Inflammatory reactions may be addressed with anti-inflammatory medications or device replacement.

Prognosis and Follow-Up

Prognosis depends on the severity of infection, timely intervention, and underlying health. Early treatment improves outcomes, but complications like neurological damage or recurrent infections can occur. Regular follow-up with neurosurgical evaluation is recommended to monitor device function and detect recurrence.

Complications

• Meningitis or ventriculitis
• Shunt malfunction or obstruction
• Neurological deficits (e.g., weakness, cognitive changes)
• Chronic infection requiring long-term therapy
• Increased intracranial pressure leading to herniation

Lifestyle & Prevention

• Maintain strict sterile technique during shunt site care
• Follow healthcare provider instructions for wound care and hygiene
• Report any signs of infection (e.g., redness, drainage) promptly
• Avoid activities that may increase infection risk (e.g., unclean environments)
• Ensure regular medical follow-up for device monitoring

When to Seek Professional Help

Seek immediate medical attention if experiencing severe headache, fever, confusion, seizures, or signs of shunt site infection (e.g., redness, swelling, drainage). These symptoms may indicate a serious complication requiring urgent intervention.

Tips for Medical Coders

Use T85.730 for infections or inflammatory reactions specifically due to a ventricular intracranial (communicating) shunt. Document the clinical correlation between the shunt and the reaction, including any microbiological or imaging findings. Ensure the code is not used for non-device-related infections or for shunts not classified as ventricular intracranial (communicating).